CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED EFFICACY ANALYSIS OF PHASE 3 CLINICAL TRIALS ACROSS BASELINE RHEUMATOID FACTOR QUARTILES
Author(s) -
Ricardo Machado Xavier,
Yoshiya Tanaka,
Zhanguo Li,
Nevsun İnanç,
Nicola Tilt,
Carlos Cara,
Carine Saadoun,
Tsutomu Takeuchi
Publication year - 2021
Publication title -
anais do congresso brasileiro de reumatologia 2020
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2020.17164
Subject(s) - certolizumab pegol , rheumatoid arthritis , medicine , quartile , rheumatoid factor , clinical trial , adalimumab , confidence interval
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom